Japan prospective multicenter study for the optimization of the COVID-19 vaccination based on the immune response and safety profile in inflammatory bowel disease patients
Not Applicable
- Conditions
- inflammatory bowel disease (ulcerative colitis, Crohn's disease)
- Registration Number
- JPRN-UMIN000043545
- Lead Sponsor
- Hyogo College of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
Not provided
Exclusion Criteria
1) The patients with active COVID-19 2) The patients with inflammatory bowel disease or persons who are not vaccinated. 3) The patients with inflammatory bowel disease or persons who are less than 16 years old.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method